DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-$$α$$ Inhibition for Cancer and Autoimmune Disease

Abstract

Tumor necrosis factor alpha (TNF-α) has both positive and negative roles in human disease. In certain cancers, TNF-α is infused locally to promote tumor regression, but dose-limiting inflammatory effects limit broader utility. In autoimmune disease, anti-TNF-α antibodies control inflammation in most patients, but these benefits are offset during chronic treatment. TAK1 acts as a key mediator between survival and cell death in TNF-α-mediated signaling. In this paper, we describe Takinib, a potent and selective TAK1 inhibitor that induces apoptosis following TNF-α stimulation in cell models of rheumatoid arthritis and metastatic breast cancer. We demonstrate that Takinib is an inhibitor of autophosphorylated and non-phosphorylated TAK1 that binds within the ATP-binding pocket and inhibits by slowing down the rate-limiting step of TAK1 activation. Overall, Takinib is an attractive starting point for the development of inhibitors that sensitize cells to TNF-α-induced cell death, with general implications for cancer and autoimmune disease treatment.

Authors:
; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER); Welch Foundation; Cancer Prevention and Research Institute of Texas (CPRIT); National Institutes of Health (NIH); ORNL Ralph E. Powe Junior Faculty Enhancement Award; Fulbright Scholar Program
OSTI Identifier:
1464982
Alternate Identifier(s):
OSTI ID: 1510249
Grant/Contract Number:  
AC02-06CH11357
Resource Type:
Published Article
Journal Name:
Cell Chemical Biology
Additional Journal Information:
Journal Name: Cell Chemical Biology Journal Volume: 24 Journal Issue: 8; Journal ID: ISSN 2451-9456
Publisher:
Cell Press - Elsevier
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; kinase inhibitors; drug discovery; enzyme kinetics; cancer; inflammatory disorders; autoimmune disease

Citation Formats

Totzke, Juliane, Gurbani, Deepak, Raphemot, Rene, Hughes, Philip F., Bodoor, Khaldon, Carlson, David A., Loiselle, David R., Bera, Asim K., Eibschutz, Liesl S., Perkins, Marisha M., Eubanks, Amber L., Campbell, Phillip L., Fox, David A., Westover, Kenneth D., Haystead, Timothy A. J., and Derbyshire, Emily R. Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-$α$ Inhibition for Cancer and Autoimmune Disease. United States: N. p., 2017. Web. doi:10.1016/j.chembiol.2017.07.011.
Totzke, Juliane, Gurbani, Deepak, Raphemot, Rene, Hughes, Philip F., Bodoor, Khaldon, Carlson, David A., Loiselle, David R., Bera, Asim K., Eibschutz, Liesl S., Perkins, Marisha M., Eubanks, Amber L., Campbell, Phillip L., Fox, David A., Westover, Kenneth D., Haystead, Timothy A. J., & Derbyshire, Emily R. Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-$α$ Inhibition for Cancer and Autoimmune Disease. United States. https://doi.org/10.1016/j.chembiol.2017.07.011
Totzke, Juliane, Gurbani, Deepak, Raphemot, Rene, Hughes, Philip F., Bodoor, Khaldon, Carlson, David A., Loiselle, David R., Bera, Asim K., Eibschutz, Liesl S., Perkins, Marisha M., Eubanks, Amber L., Campbell, Phillip L., Fox, David A., Westover, Kenneth D., Haystead, Timothy A. J., and Derbyshire, Emily R. Thu . "Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-$α$ Inhibition for Cancer and Autoimmune Disease". United States. https://doi.org/10.1016/j.chembiol.2017.07.011.
@article{osti_1464982,
title = {Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-$α$ Inhibition for Cancer and Autoimmune Disease},
author = {Totzke, Juliane and Gurbani, Deepak and Raphemot, Rene and Hughes, Philip F. and Bodoor, Khaldon and Carlson, David A. and Loiselle, David R. and Bera, Asim K. and Eibschutz, Liesl S. and Perkins, Marisha M. and Eubanks, Amber L. and Campbell, Phillip L. and Fox, David A. and Westover, Kenneth D. and Haystead, Timothy A. J. and Derbyshire, Emily R.},
abstractNote = {Tumor necrosis factor alpha (TNF-α) has both positive and negative roles in human disease. In certain cancers, TNF-α is infused locally to promote tumor regression, but dose-limiting inflammatory effects limit broader utility. In autoimmune disease, anti-TNF-α antibodies control inflammation in most patients, but these benefits are offset during chronic treatment. TAK1 acts as a key mediator between survival and cell death in TNF-α-mediated signaling. In this paper, we describe Takinib, a potent and selective TAK1 inhibitor that induces apoptosis following TNF-α stimulation in cell models of rheumatoid arthritis and metastatic breast cancer. We demonstrate that Takinib is an inhibitor of autophosphorylated and non-phosphorylated TAK1 that binds within the ATP-binding pocket and inhibits by slowing down the rate-limiting step of TAK1 activation. Overall, Takinib is an attractive starting point for the development of inhibitors that sensitize cells to TNF-α-induced cell death, with general implications for cancer and autoimmune disease treatment.},
doi = {10.1016/j.chembiol.2017.07.011},
journal = {Cell Chemical Biology},
number = 8,
volume = 24,
place = {United States},
year = {Thu Aug 17 00:00:00 EDT 2017},
month = {Thu Aug 17 00:00:00 EDT 2017}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
https://doi.org/10.1016/j.chembiol.2017.07.011

Citation Metrics:
Cited by: 89 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Cellular Localization of Tumor Necrosis Factor- α Following Acute Spinal Cord Injury in Adult Rats
journal, May 2001


TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
journal, February 2012


Tumor necrosis factor signaling
journal, January 2003

  • Wajant, H.; Pfizenmaier, K.; Scheurich, P.
  • Cell Death & Differentiation, Vol. 10, Issue 1
  • DOI: 10.1038/sj.cdd.4401189

Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
journal, November 2001


TAK1–TAB2 Signaling Contributes to Bone Destruction by Breast Carcinoma Cells
journal, June 2011


Characterization of a UBC13 kinase in Plasmodium falciparum
journal, April 2007

  • Philip, N.; Haystead, T. A.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 19
  • DOI: 10.1073/pnas.0611601104

NF-κB in colorectal cancer
journal, May 2013

  • Vaiopoulos, Aristeidis G.; Athanasoula, Kalliopi Ch.; Papavassiliou, Athanasios G.
  • Journal of Molecular Medicine, Vol. 91, Issue 9
  • DOI: 10.1007/s00109-013-1045-x

TAK1 regulates hepatic cell survival and carcinogenesis
journal, January 2014


TAK1 selective inhibition: state of the art and future opportunities
journal, January 2015

  • Kilty, Iain; Jones, Lyn H.
  • Future Medicinal Chemistry, Vol. 7, Issue 1
  • DOI: 10.4155/fmc.14.138

TAK1 is required for TGF-β1-mediated regulation of matrix metalloproteinase-9 and metastasis
journal, September 2007


NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling
journal, June 2001


Optical and Radioiodinated Tethered Hsp90 Inhibitors Reveal Selective Internalization of Ectopic Hsp90 in Malignant Breast Tumor Cells
journal, September 2013


LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
journal, January 1995

  • Wallace, Andrew C.; Laskowski, Roman A.; Thornton, Janet M.
  • "Protein Engineering, Design and Selection", Vol. 8, Issue 2
  • DOI: 10.1093/protein/8.2.127

Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade
journal, September 2014

  • Wu, X.; Zhang, W.; Font-Burgada, J.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 38
  • DOI: 10.1073/pnas.1414358111

Isolated Limb Perfusion with Melphalan and TNF-α in the Treatment of Extremity Sarcoma
journal, December 2007

  • Verhoef, Cornelis; de Wilt, Johannes H. W.; Grünhagen, Dirk J.
  • Current Treatment Options in Oncology, Vol. 8, Issue 6
  • DOI: 10.1007/s11864-007-0044-y

TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
journal, November 2005


Remission in ankylosing spondylitis treated with anti-TNF-  drugs: a national multicentre study
journal, July 2013


Assay of protein kinases using radiolabeled ATP: a protocol
journal, August 2006

  • Hastie, C. James; McLauchlan, Hilary J.; Cohen, Philip
  • Nature Protocols, Vol. 1, Issue 2
  • DOI: 10.1038/nprot.2006.149

Autoactivation of Transforming Growth Factor β-activated Kinase 1 Is a Sequential Bimolecular Process
journal, August 2010

  • Scholz, Roland; Sidler, Corinne L.; Thali, Ramon F.
  • Journal of Biological Chemistry, Vol. 285, Issue 33
  • DOI: 10.1074/jbc.M109.093468

Molecular Interactions between T Cells and Fibroblast-Like Synoviocytes
journal, November 2007

  • Tran, Chinh N.; Lundy, Steven K.; White, Peter T.
  • The American Journal of Pathology, Vol. 171, Issue 5
  • DOI: 10.2353/ajpath.2007.070004

Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors
journal, October 2015

  • Francini, Cinzia Maria; Fallacara, Anna Lucia; Artusi, Roberto
  • ChemMedChem, Vol. 10, Issue 12
  • DOI: 10.1002/cmdc.201500428

Phase I Study of a Combination of Recombinant Tumor Necrosis Factor-α and Recombinant Interferon-γ in Cancer Patients
journal, August 1989

  • Kurzrock, Razelle; Feinberg, Bruce; Talpaz, Moshe
  • Journal of Interferon Research, Vol. 9, Issue 4
  • DOI: 10.1089/jir.1989.9.435

TAK1 Mitogen-activated Protein Kinase Kinase Kinase Is Activated by Autophosphorylation within Its Activation Loop
journal, March 2000

  • Kishimoto, Kazuya; Matsumoto, Kunihiro; Ninomiya-Tsuji, Jun
  • Journal of Biological Chemistry, Vol. 275, Issue 10
  • DOI: 10.1074/jbc.275.10.7359

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
journal, May 2012


TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
journal, October 2004


MUC1-C activates the TAK1 inflammatory pathway in colon cancer
journal, February 2015


Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)
journal, July 2014

  • Tan, Li; Nomanbhoy, Tyzoon; Gurbani, Deepak
  • Journal of Medicinal Chemistry, Vol. 58, Issue 1
  • DOI: 10.1021/jm500480k

Targeting of TAK1 in inflammatory disorders and cancer
journal, October 2012


Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
journal, March 2013


p38 Mitogen-Activated Protein Kinase Promotes Cell Survival in Response to DNA Damage but Is Not Required for the G2 DNA Damage Checkpoint in Human Cancer Cells
journal, June 2010

  • Phong, Mark S.; Van Horn, Robert D.; Li, Shuyu
  • Molecular and Cellular Biology, Vol. 30, Issue 15
  • DOI: 10.1128/MCB.00949-09

Breast Tumor Cell Lines From Pleural Effusions2
journal, September 1974

  • Cailleau, R.; Young, R.; Olivé, M.
  • JNCI: Journal of the National Cancer Institute, Vol. 53, Issue 3
  • DOI: 10.1093/jnci/53.3.661

Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5 Z )-7-Oxozeaenol
journal, January 2013

  • Wu, Jiaquan; Powell, Francoise; Larsen, Nicholas A.
  • ACS Chemical Biology, Vol. 8, Issue 3
  • DOI: 10.1021/cb3005897

Identification of an Allosteric Small-Molecule Inhibitor Selective for the Inducible Form of Heat Shock Protein 70
journal, December 2014


The druggable genome
journal, September 2002

  • Hopkins, Andrew L.; Groom, Colin R.
  • Nature Reviews Drug Discovery, Vol. 1, Issue 9
  • DOI: 10.1038/nrd892

Post-Translational Modifications of the TAK1-TAB Complex
journal, January 2017

  • Hirata, Yusuke; Takahashi, Miki; Morishita, Tohru
  • International Journal of Molecular Sciences, Vol. 18, Issue 1
  • DOI: 10.3390/ijms18010205

HKL -3000: the integration of data reduction and structure solution – from diffraction images to an initial model in minutes
journal, July 2006

  • Minor, Wladek; Cymborowski, Marcin; Otwinowski, Zbyszek
  • Acta Crystallographica Section D Biological Crystallography, Vol. 62, Issue 8
  • DOI: 10.1107/S0907444906019949

Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4
journal, June 2006

  • Powers, Jay P.; Li, Shyun; Jaen, Juan C.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 16, Issue 11
  • DOI: 10.1016/j.bmcl.2006.03.020

Treatment modifications in tumour necrosis factor-α (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas
journal, February 2015

  • Deroose, Jan P.; Grünhagen, Dirk J.; de Wilt, Johannes H. W.
  • European Journal of Cancer, Vol. 51, Issue 3
  • DOI: 10.1016/j.ejca.2014.11.020

TAK1-mediated stress signaling pathways are essential for TNF-α-promoted pulmonary metastasis of murine colon cancer cells
journal, January 2006

  • Choo, Min-Kyung; Sakurai, Hiroaki; Koizumi, Keiichi
  • International Journal of Cancer, Vol. 118, Issue 11
  • DOI: 10.1002/ijc.21734

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

REFMAC 5 for the refinement of macromolecular crystal structures
journal, March 2011

  • Murshudov, Garib N.; Skubák, Pavol; Lebedev, Andrey A.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444911001314

PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
  • DOI: 10.1107/S0907444909052925

Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2 + Breast Cancer
journal, June 2016


Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells
journal, October 1994


Pulmonary Toxicity of Recombinant Human Tumor Necrosis Factor
journal, August 1989


A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity
journal, December 2013

  • Levinson, Nicholas M.; Boxer, Steven G.
  • Nature Chemical Biology, Vol. 10, Issue 2
  • DOI: 10.1038/nchembio.1404

The Purinome, a Complex Mix of Drug and Toxicity Targets
journal, June 2006


Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis
journal, December 2009

  • Inokuchi, S.; Aoyama, T.; Miura, K.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 2
  • DOI: 10.1073/pnas.0909781107

IRAK signalling in cancer
journal, October 2014

  • Rhyasen, G. W.; Starczynowski, D. T.
  • British Journal of Cancer, Vol. 112, Issue 2
  • DOI: 10.1038/bjc.2014.513

Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation
journal, October 2016

  • Jones, Douglas S.; Jenney, Anne P.; Swantek, Jennifer L.
  • Nature Chemical Biology, Vol. 13, Issue 1
  • DOI: 10.1038/nchembio.2211

Avogadro: an advanced semantic chemical editor, visualization, and analysis platform
journal, August 2012

  • Hanwell, Marcus D.; Curtis, Donald E.; Lonie, David C.
  • Journal of Cheminformatics, Vol. 4, Issue 1
  • DOI: 10.1186/1758-2946-4-17

TNF-mediated inflammatory disease
journal, January 2008


Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
journal, July 1999

  • Moore, Robert J.; Owens, David M.; Stamp, Gordon
  • Nature Medicine, Vol. 5, Issue 7
  • DOI: 10.1038/10552

TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells
journal, September 2016

  • Wang, Zhenyu; Zhang, Huiyuan; Shi, Minghao
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep32737

Fluorescence Linked Enzyme Chemoproteomic Strategy for Discovery of a Potent and Selective DAPK1 and ZIPK Inhibitor
journal, October 2013

  • Carlson, David A.; Franke, Aaron S.; Weitzel, Douglas H.
  • ACS Chemical Biology, Vol. 8, Issue 12
  • DOI: 10.1021/cb400407c

A Kinetic Test Characterizes Kinase Intramolecular and Intermolecular Autophosphorylation Mechanisms
journal, July 2013